BLISS GVS PHARMABLISS GVS PHARMABLISS GVS PHARMA

BLISS GVS PHARMA

No trades
See on Supercharts
Market capitalization
‪11.48 B‬INR
‪708.59 M‬INR
‪7.47 B‬INR
‪36.52 M‬
Beta (1Y)
1.26

About BLISS GVS PHARMA

CEO
Gagan Harsh Sharma
Headquarters
Mumbai
Employees (FY)
763
Founded
1984
ISIN
INE416D01022
FIGI
BBG000BHSFQ7
Bliss GVS Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations. Its products include capsules; creams, gels, and ointment; dry powder for injection and oral suspension; effervescent tablets; eye and ear drops; injection; liquid preparations; lotions; lozenges; nasal solution; oral solids; parenteral; pessaries; sachets; soft gelatin capsules; suppositories; suspension; syrups; tablets; and topical preparations. The company was founded on December 11, 1984 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BLISSGVS is 114.00 INR — it has decreased by 1.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange BLISS GVS PHARMA stocks are traded under the ticker BLISSGVS.
BLISS GVS PHARMA is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
BLISSGVS stock is 3.13% volatile and has beta coefficient of 1.26. Check out the list of the most volatile stocks — is BLISS GVS PHARMA there?
Yes, you can track BLISS GVS PHARMA financials in yearly and quarterly reports right on TradingView.
BLISSGVS stock has risen by 3.35% compared to the previous week, the month change is a 0.40% rise, over the last year BLISS GVS PHARMA has showed a 49.70% increase.
BLISSGVS net income for the last quarter is ‪276.10 M‬ INR, while the quarter before that showed ‪423.07 M‬ INR of net income which accounts for −34.74% change. Track more BLISS GVS PHARMA financial stats to get the full picture.
Today BLISS GVS PHARMA has the market capitalization of ‪12.10 B‬, it has decreased by 2.38% over the last week.
Yes, BLISSGVS dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.43%. Tracking BLISS GVS PHARMA dividends might help you take more informed decisions.
BLISS GVS PHARMA dividend yield was 0.70% in 2022, and payout ratio reached 7.32%. The year before the numbers were 0.65% and 34.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, BLISSGVS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLISS GVS PHARMA stock right from TradingView charts — choose your broker and connect to your account.
BLISSGVS reached its all-time high on Dec 30, 2020 with the price of 221.00 INR, and its all-time low was 18.80 INR and was reached on Oct 3, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 763.00 employees. See our rating of the largest employees — is BLISS GVS PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BLISS GVS PHARMA technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BLISS GVS PHARMA stock shows the buy signal. See more of BLISS GVS PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BLISS GVS PHARMA EBITDA is ‪1.29 B‬ INR, and current EBITDA margin is 15.59%. See more stats in BLISS GVS PHARMA financial statements.